EBSCommon stockNYSE
EBS Common stock
This is the ticker-level security page. The issuer is Emergent BioSolutions Inc..
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$788.9M
Net income TTM
$75.9M
Total assets
$1.5B
Total debt
$693.1M
Total equity
$582.5M
Profit margin
9.6%
ROE
13%
ROA
5.2%
Latest issuer financial snapshot: 2024-12-31